(Q44603279)

4 December 2017

title

Dose-related pharmacokinetics and pharmacodynamics of valproate in the elderly (English)

1 reference

4 December 2017

Dose-Related Pharmacokinetics and Pharmacodynamics of Valproate in the Elderly (English)

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

16 March 2024

1 reference

1 reference

Susy Felix

1

1 reference

4 December 2017

Beth A. Sproule

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14520124

16 March 2024

Brian G. Hardy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14520124

16 March 2024

Claudio A. Naranjo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14520124

16 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://journals.lww.com/10.1097/01.jcp.0000088903.24613.2a

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Journal of Clinical Psychopharmacology

16 March 2024

published in

1 reference

4 December 2017

volume

23

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

471-478

1 reference

Valproic acid dosage and plasma protein binding and clearance

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Pharmacokinetics of valproic acid in young and elderly subjects

16 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Pharmacokinetics of valproic acid in the elderly

16 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults

16 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

CYP4 isozyme specificity and the relationship between omega-hydroxylation and terminal desaturation of valproic acid

16 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

16 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Metabolic profiling of valproic acid by cDNA-expressed human cytochrome P450 enzymes using negative-ion chemical ionization gas chromatography-mass spectrometry.

16 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Interaction of serotonin uptake inhibitors with ethanol

16 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Acute kinetic and dynamic interactions of zimelidine with ethanol

16 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Ethanol interactions with serotonin uptake selective and non-selective antidepressants: Fluoxetine and amitriptyline

16 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Sedative effects and impaired learning and recall after single oral doses of lorazepam.

16 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Sensitivity to triazolam in the elderly.

16 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Kinetic and dynamic interactions of oral viqualine and ethanol in man.

16 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Validity of the Trail Making Test as an Indicator of Organic Brain Damage

16 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

16 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Aspects on pharmacokinetics of some diuretics

16 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Pharmacokinetics of oestrogens and progestogens

16 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Plasma protein binding kinetics of valproic acid over a broad dosage range: therapeutic implications

16 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy

16 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Effect of valproate dose on formation of hepatotoxic metabolites

16 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Metabolism and excretion of mood stabilizers and new anticonvulsants

16 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Accumulation and washout kinetics of valproic acid and its active metabolites

16 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Pharmacological evaluation of various metabolites and analogues of valproic acid. Anticonvulsant and toxic potencies in mice

16 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

Relation of serum valproate concentration to response in mania

16 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/01.JCP.0000088903.24613.2A

16 March 2024

Identifiers

1 reference

4 December 2017

1 reference